AAMC meet highlights need for research funds

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.

VU, Bristol-Myers to collaborate on Parkinson’s therapies

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.

Mchaourab to lead Chemical and Physical Biology program

Hassane Mchaourab, Ph.D., professor of Molecular Physiology & Biophysics, Physics and Chemistry, has been named the new director of the Ph.D.-granting Chemical and Physical Biology (CPB) program at Vanderbilt University.

VUMC poised to lead as health care reform evolves

Congress has not yet figured out how to reduce the national debt without slashing health care spending and research. How will Vanderbilt University Medical Center respond?

Getting Personal

Charo set for season’s first Flexner Discovery Lecture

R. Alto Charo, J.D., a nationally known bioethicist at the University of Wisconsin Law School in Madison, will deliver the first Flexner Discovery Lecture on Thursday, Sept. 20.